Managers
Insurity, a provider of cloud-based software for property and casualty (P&C) carriers, brokers, and MGAs has secured a strategic growth investment from global growth private equity firm TA Associates.
TA, along with Insurity’s current investor GI Partners, plan to further accelerate Insurity’s growth and expand the delivery of the P&C insurance industry’s most configurable, cloud-native, and intuitively analytical software platforms.
Founded in 1985 and headquartered in Hartford, CT, Insurity has built a team of nearly 1,500 team members globally. The team’s deep industry expertise and software offerings supporting the entire policy lifecycle have enabled it to build a strong
EQT is to acquire LSP (Life Sciences Partners), a European life sciences venture capital firm with approximately EUR2.2 billion of assets under management (AUM) and a team of 34 professionals.
LSP, headquartered in Amsterdam, the Netherlands, is a venture capital firm that invests in innovative companies with strong scientific and clinical rationale across several life sciences strategies. The Company was founded in 1998 and today is one of Europe’s largest and most experienced life sciences investment firms. LSP employs 34 professionals across its offices in Amsterdam, Munich, and Boston.
Over the past two decades, LSP has invested in over
Thompson Street Capital Partners (TSCP) portfolio company PestCo Holdings, LLC (PestCo), an acquisition company formed to consolidate the highly fragmented pest control industry, acquired the assets of Presto Pest Control, Inc (Presto).
Located in Telford, PA and founded in 1999, Presto is a provider of commercial pest control services in the middle Atlantic with a particular focus on serving the restaurant industry. Presto is PestCo’s first acquisition. Terms of the transaction were not disclosed.
Jay Keating, CEO of PestCo, says: “Presto is an ideal starting point for our consolidation efforts at PestCo. Ken Fox has built a high-quality
Kudo Insurance (Kudo) has started fundraising for its Series A, as it launches its new app designed to radically change how insurance is typically consumed, priced and distributed.
The business has a five-year ambition of becoming the most profitable and popular insurer in the UK, notable given the sector’s recent struggle to deliver profit. The market Kudo is addressing is a sizeable one, with GBP16 billion of gross written premiums in 2019, but the sector is loss making and suffers significant reputation and trust issues. Kudo believes by being mobile first and harnessing great technology and product it can start
VSS Capital Partners (VSS), a private investment firm investing in the healthcare, information, business services and education industries, has invested in The HFW Companies (HFW), a newly formed platform and partnership focused on investing in architecture, engineering, and construction (AEC) services firms.
Concurrently, HFW has introduced its first member firm – Miller Legg, an award-winning multi-disciplinary engineering and consulting firm based in Fort Lauderdale, Florida. Financial terms of the transactions have not been disclosed.
Headquartered in St Louis, Missouri, HFW is led by an executive team of three industry veterans who have experience in AEC services including prior operating,
Clayton, Dubilier & Rice has completed the sale of Solenis, a leading global supplier of specialty chemicals and services forwater treatment applications, to Platinum Equity.
Renaissance (Renaissance), a specialist in pre-K–12 educational technology, has secured a significant equity investment from private equity funds managed by Blackstone alongside existing investors including Francisco Partners and TPG’s The Rise Fund.
Francisco Partners, a leading global investment firm that specialiaes in partnering with technology businesses, acquired the Company in 2018 and will remain a major shareholder. Blackstone’s investment will be made through its flagship private equity vehicle.
Founded in 1986, Renaissance combines decades of experience in assessments with personalised instruction and analytics solutions delivering teachers and administrators the tools to plan, lessons to teach, and the resources to motivate
Confluence Technologies (Confluence), a technology solutions provider helping the investment management industry solve complex investment data challenges, is to acquire Compliance Solutions Strategies (CSS), a global regulatory software (RegTech) company that enables financial services firms to meet mandatory regulatory compliance requirements.
Confluence is backed by Clearlake Capital Group and TA Associates (TA).
Founded in 2017 and headquartered in New York, CSS offers clients a next-generation global RegTech platform underpinned by its proprietary Regulatory Book of Record (RBOR) data management solution. Servicing more than 600 clients globally, including nine of the top 10 global asset managers and six of the
Fast-growing IT services company Acora has made a third bolt-on acquisition since the investment by Palatine in 2020, and is planning to ramp up further deals in 2022.
The latest deal, for London-based M9 Limited, brings a thriving and forward-looking IT services provider with over 40 staff, and nearly 100 long-term contracted customers to Acora Group.
Founded in 1990, M9 has also established a strong international presence with an offshore team in Kuala Lumpur.
Since Palatine’s initial investment of in the Acora Group in 2020, as a result of the three acquisitions – Veber Ltd, Westgate and now M9 Limited
Novo Holdings, aa international life science investor, has co-led the EUR6 million seed financing in Asgard Therapeutics AB (Asgard), a private biotech company pioneering in vivo direct cell reprogramming approaches to elicit potent anti-cancer immune responses.
Asgard pioneers a novel approach to cancer therapy by reprogramming tumor cells into professional antigen presenting cells. Asgard’s lead program is an off-the-shelf gene therapy that induces a personalised immune response. The approach may also help overcome logistic and manufacturing hurdles of more conventional cell-based therapies.
The Company stems from the Lund University’s Cell Reprogramming and Immunity Lab, led by Professor Filipe Pereira,
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
